Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M.
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
PMID:31995683
Uveal melanoma: relatively rare but deadly cancer.
Kaliki S, Shields CL.
Eye (Lond). 2017 Feb;31(2):241-257. doi: 10.1038/eye.2016.275. Epub 2016 Dec 2.
PMID:27911450
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J, Murray N.
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):286-295. doi: 10.1016/j.ijrobp.2017.01.008. Epub 2017 Jan 6.
PMID:28433432
[Retinoblastoma update].
Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F.
Arch Pediatr. 2016 Jan;23(1):112-6. doi: 10.1016/j.arcped.2015.09.025. Epub 2015 Dec 8.
PMID:26679524
The Risk of Postoperative Periprosthetic Femoral Fracture After Total Hip Arthroplasty Depends More on Stem Design Than Cement Use: An Analysis of National Health Data from England.
Lamb JN, West RM, Relton SD, Wilkinson JM, Pandit HG.
J Bone Joint Surg Am. 2025 Mar 5;107(5):476-487. doi: 10.2106/JBJS.24.00894. Epub 2025 Jan 28.
PMID:39874379
Who Will Benefit from Charged-Particle Therapy?
Kim KS, Wu HG.
Cancer Res Treat. 2021 Jul;53(3):621-634. doi: 10.4143/crt.2021.299. Epub 2021 Jun 21.
PMID:34176253
The management of retinoblastoma.
Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, Ohnuma SI, Reddy MA, Sagoo MS.
Oncogene. 2018 Mar;37(12):1551-1560. doi: 10.1038/s41388-017-0050-x. Epub 2018 Jan 11.